Thermo Fisher Scientific Inc. · TMO · Next earnings

Thermo Fisher Scientific Inc. reports Thursday, Feb 4, 2027

TMO reports before market open with consensus EPS at $7.13 and revenue at $12.84B. Last quarter: Thermo Fisher raises 2026 guidance as pharma services and AI support growth

Reports Before market open91 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $7.13 Calendar consensus
Consensus revenue $12.84B Calendar consensus
Report date Feb 4, 2027 Thursday, date estimated
Session Before market open 91 days away

Where TMO left off: FY2026 Q3

Full report

Thermo Fisher raises 2026 guidance as pharma services and AI support growth

EPS surprise +4.4% Reported $6.68 vs $6.40
Revenue surprise +1.5% Reported $12.14B vs $11.95B
Stock move +1.0% Event window
Subsequent drift 0.0% Up to 20 sessions

Management raised full-year 2026 guidance to $47.7-$48.2 billion of revenue and $25.13-$25.43 of EPS, from $47.4-$48.1 billion and $24.93-$25.33 previously.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Recent acquisition integration may not deliver expected synergies.
  • A one-time tariff refund benefit will not recur.
  • Foreign-exchange volatility and unfavorable product mix could affect results.
  • New diagnostic launches remain subject to regulatory approvals.

Questions analysts left open

  • Organic growth by end market and region, particularly pharma versus biotech.
  • The timing of Pharma Services revenue into Q4 and its effect on guidance.
  • The pace of Clario integration and expected synergies.
  • How AI contributes to revenue over the medium and long term.

Ask FN2 about TMO next report

Transcript, numbers and history already loaded
What should I watch for in TMO's next earnings report?How did TMO guide last quarter, and is consensus above or below that?Give me the bull and bear case going into TMO earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the TMO recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent TMO quarters

All TMO earnings
+1.0%FY2026 Q3+8.7%FY2026 Q2-9.2%FY2026 Q1-2.6%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.